Calidi Biotherapeutics Inc. (CLDI)

Calidi Biotherapeutics Inc. (CLDI) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $2.8M; returns 1 day -0.8%, 1 week -23.0%, 1 year -97.3%.

Calidi Biotherapeutics, Inc. (CLDI) is a clinical-stage immuno-oncology company focused on developing allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses. Their approach centers on oncolytic virotherapy, utilizing genetically modified viruses to selectively infect and destroy cancer cells while stimulating anti-tumor immune responses.

Groups CLDI belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Oncology
• Immunotherapy
• Healthcare
• Cancer Therapeutics
• Life Sciences
• Biopharmaceutical
• Clinical Stage

CLDI financial model: income statement, cash flow and balance sheet